Lucy Therapeutics, Inc.
Lucy Therapeutics is a biotech company providing effective treatments for neurological diseases start with the mitochondria. The company is offering a differentiated approach to drug discovery by drugging targets associated with early disease pathogenesis. The company's approach can also be expanded to provide new options for treating similar neurologically focused diseases including Parkinson's Disease (PD) and Alzheimer's Disease (AD).
Industries
Nr. of Employees
medium (51-250)
Lucy Therapeutics, Inc.
Cambridge, Massachusetts, United States, North America
Products
Mitochondrial-based small molecule therapies
Develops therapies targeting mitochondrial dysfunction for treating complex diseases, with a focus on neurological disorders.
Diagnostic biomarkers
Identifies biomarkers for the diagnosis and progression monitoring of diseases related to mitochondrial dysfunction.
Parkinson's disease program
A lead program focused on developing treatments for Parkinson's disease through targeting mitochondrial dysfunction.
Rett syndrome program
An advanced program aimed at developing treatments for Rett syndrome by addressing mitochondrial dysfunction.
Early discovery efforts for undisclosed targets
Research and development efforts targeting undisclosed diseases susceptible to mitochondrial dysfunction.
Mitochondrial-based small molecule therapies
Develops therapies targeting mitochondrial dysfunction for treating complex diseases, with a focus on neurological disorders.
Diagnostic biomarkers
Identifies biomarkers for the diagnosis and progression monitoring of diseases related to mitochondrial dysfunction.
Parkinson's disease program
A lead program focused on developing treatments for Parkinson's disease through targeting mitochondrial dysfunction.
Rett syndrome program
An advanced program aimed at developing treatments for Rett syndrome by addressing mitochondrial dysfunction.
Early discovery efforts for undisclosed targets
Research and development efforts targeting undisclosed diseases susceptible to mitochondrial dysfunction.